PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
10-Oct-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab) SC-based quadruplet regimen for newly diagnosed multiple myeloma patients Johnson & Johnson
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis
10-Oct-2024 Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public GWI research
10-Oct-2024 Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer Curve Therapeutics
10-Oct-2024 Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 Antag Therapeutics
10-Oct-2024 PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting PureTech Health plc
10-Oct-2024 Purespring Therapeutics raises £80 million in a Series B financing Syncona Ltd
10-Oct-2024 New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Sanofi
10-Oct-2024 Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer Driven by EGFR Exon 19 or 21 and Co-occurring C797S Mutations Pierre Fabre Laboratories
10-Oct-2024 ACG Accelerates European Growth with Major Expansion in Croatia ACG
10-Oct-2024 Vivanti Unveils COSMART AVA at the 14th Annual Sales Force Effectiveness and Digital Marketing in Pharma Summit Berlin, 16th October 2024 Vivanti
10-Oct-2024 Mestag Therapeutics Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases Mestag Therapeutics
10-Oct-2024 Elafibranor approved as first medicine to treat adults with a rare liver disease known as primary biliary cholangitis MHRA
10-Oct-2024 Life sciences marketing specialist PHD Marketing rebrands to Think B2B Marketing Think B2B Marketing
10-Oct-2024 Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute Veranova
10-Oct-2024 Call for urgent global research into the mental health impacts of extreme heat The Physiological Society 
09-Oct-2024 Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public Roche
08-Oct-2024 ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society ProQR Therapeutics
08-Oct-2024 Bespak & H&T Presspart announce availability of GMP pilot line for low GWP pMDIs Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze Bespak